News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
488,249 Results
Type
Article (8198)
Company Profile (144)
Press Release (479745)
Multimedia
Podcasts (5)
Webinars (6)
Section
Business (167302)
Career Advice (327)
Deals (25833)
Drug Delivery (9)
Drug Development (52904)
Employer Resources (19)
FDA (9778)
Job Trends (8621)
News (238831)
Policy (17941)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (504)
Accelerated approval (26)
ADA (20)
Adcomms (1)
Allergies (99)
Alliances (33393)
ALS (113)
Alzheimer's disease (987)
Antibody-drug conjugate (ADC) (285)
Approvals (10447)
Artificial intelligence (346)
ASCO (159)
Autoimmune disease (223)
Automation (30)
Bankruptcy (264)
Belgium (1)
Best Places to Work (6999)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (22)
Biotechnology (91)
Bispecific (1)
Bladder cancer (140)
Brain cancer (31)
Breast cancer (522)
Cancer (3786)
Cardiovascular disease (228)
Career advice (263)
Career pathing (1)
CAR-T (179)
CDC (1)
CDMO (23)
Celiac Disease (1)
Cell therapy (493)
Cervical cancer (35)
Clinical research (48128)
Collaboration (1299)
Commercialization (3)
Compensation (1538)
Complete response letters (34)
COVID-19 (770)
CRISPR (65)
C-suite (812)
Cystic fibrosis (89)
Data (5906)
Denatured (5)
Depression (107)
Dermatology (68)
Diabetes (361)
Diagnostics (4247)
Digital health (39)
Diversity (2)
Diversity, equity & inclusion (5)
Drug discovery (168)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73869)
Editorial (1)
Employer branding (3)
Employer resources (18)
Events (88363)
Executive appointments (718)
FDA (12548)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (964)
Gene editing (127)
Generative AI (12)
Gene therapy (339)
GLP-1 (301)
Government (966)
Grass and pollen (2)
Guidances (281)
Healthcare (9426)
Hematology (94)
HIV (58)
Huntington's disease (23)
IgA nephropathy (68)
Immunology and inflammation (108)
Immuno-oncology (62)
Indications (164)
Infectious disease (963)
Inflammatory bowel disease (129)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (263)
Interviews (46)
IPO (12419)
IRA (2)
Job creations (1975)
Job search strategy (251)
JPM (2)
Kidney cancer (16)
Kidney disease (46)
Layoffs (60)
Leadership (1)
Legal (5205)
Licensing (19)
Liver cancer (45)
Longevity (19)
Lung cancer (548)
Lymphoma (259)
Machine learning (29)
Management (6)
Manufacturing (578)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8786)
Medtech (8949)
Mergers & acquisitions (14477)
Metabolic disorders (736)
mRNA (68)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (229)
Neuropsychiatric disorders (40)
Neuroscience (1883)
NextGen: Class of 2026 (3176)
Non-profit (872)
Now hiring (4)
Obesity (234)
Opinion (12)
Ovarian cancer (161)
Pain (178)
Pancreatic cancer (207)
Parkinson's disease (206)
Partnered (14)
Patents (503)
Patient recruitment (532)
Patient selection (2)
Peanut (33)
People (41493)
Peptides (4)
Pharmaceutical (31)
Pharmacy benefit managers (9)
Phase 1 (15550)
Phase 2 (21498)
Phase 3 (14482)
Pipeline (7775)
Policy (19)
Postmarket research (1570)
Preclinical (6582)
Press Release (34)
Prostate cancer (193)
Psychedelics (7)
Radiopharmaceuticals (195)
Rare diseases (595)
Real estate (3046)
Recruiting (9)
Regenerative medicine (2)
Regulatory (15027)
Reports (23)
Research institute (592)
Resumes & cover letters (48)
Rett syndrome (42)
RNA editing (6)
RSV (48)
Schizophrenia (104)
Series A (168)
Series B (127)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (91)
Sponsored (6)
Startups (2038)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (52)
Vaccines (337)
Venture capital (19)
Weight loss (76)
Women's health (89)
Date
Today (64)
Last 7 days (263)
Last 30 days (1457)
Last 365 days (19178)
2026 (13815)
2025 (19336)
2024 (23095)
2023 (26630)
2022 (34718)
2021 (37297)
2020 (33621)
2019 (23481)
2018 (17611)
2017 (18874)
2016 (17987)
2015 (24391)
2014 (21734)
2013 (18200)
2012 (20272)
2011 (20482)
2010 (20392)
Location
Africa (233)
Alabama (79)
Alaska (2)
Arizona (311)
Arkansas (11)
Asia (18152)
Australia (2160)
California (12402)
Canada (3272)
China (554)
Colorado (501)
Connecticut (428)
Delaware (217)
Europe (25435)
Florida (1865)
Georgia (393)
Hawaii (3)
Idaho (46)
Illinois (734)
India (53)
Indiana (325)
Iowa (16)
Japan (430)
Kansas (103)
Kentucky (32)
Louisiana (27)
Maine (26)
Maryland (1235)
Massachusetts (8141)
Michigan (315)
Minnesota (576)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (123)
New Hampshire (60)
New Jersey (2712)
New Mexico (12)
New York (2922)
North Carolina (1321)
North Dakota (5)
Northern California (6233)
Ohio (297)
Oklahoma (14)
Oregon (16)
Pennsylvania (2306)
Puerto Rico (21)
Rhode Island (30)
South America (409)
South Carolina (78)
South Dakota (1)
Southern California (5163)
Tennessee (125)
Texas (2018)
United States (40218)
Utah (377)
Vermont (1)
Virginia (162)
Washington D.C. (39)
Washington State (959)
West Virginia (1)
Wisconsin (76)
Wyoming (1)
488,249 Results for "adm tronics unlimited inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ADM Tronics Reports Third Quarter of Fiscal Year 2026 Results
February 15, 2026
·
3 min read
Press Releases
ADM Tronics Reports Second Quarter of Fiscal Year 2026 Results
November 17, 2025
·
4 min read
Press Releases
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery
May 26, 2026
·
10 min read
Press Releases
ADM Tronics Reports First Quarter of Fiscal Year 2025 Results
August 19, 2024
·
4 min read
Press Releases
BioIVT to Showcase ADME-Tox and NAMs Expertise at Spring 2026 Industry Events
March 19, 2026
·
4 min read
IN PARTNERSHIP WITH VIVA BIOTECH
Cyclic peptides open new drug frontiers, if manufacturing can keep up
With oral cyclic peptides offering small molecule convenience and antibody‑like selectivity, the modality is gaining momentum. But bioavailability below 1%, minimal PK data and fragile synthesis still slow progress. Viva Biotech’s experts outlined how hybrid synthesis, ADME/PK modeling and AI‑guided design are expanding what peptide therapeutics can reach.
September 14, 2026
·
6 min read
·
Jennifer C. Smith-Parker
Press Releases
Adm. Craig Faller (Ret.) and Adele Gulfo Elected to Battelle Board of Directors
November 20, 2025
·
3 min read
Pharm Country
ADM Tronics Presents Outlook for 2018
ADM Tronics Unlimited today released the following investor update.
January 17, 2018
·
4 min read
Pharm Country
BioIVT to Host Symposium and Workshop in Brussels on Advanced In Vitro ADME Methodologies
BioIVT today announced it will host Small Molecules and Biologics: Advanced ADME Strategies & Techniques, a complimentary symposium and workshop on methodologies and techniques for in vitro ADME research.
April 9, 2024
·
3 min read
Business
ADM to Release Third Quarter Financial Results Oct. 24, 2023
ADM (NYSE: ADM) will release financial results for the third quarter of 2023 before the market opens on Tuesday, Oct. 24, 2023.
October 10, 2023
·
1 min read
1 of 48,825
Next
